Digestive Cancers Europe shared a post on LinkedIn:
“Listen to COR2ED’s final episode of its four-part podcast series for healthcare professionals on hepatocellular carcinoma (HCC), “Intermediate HCC – the evolving role of immunotherapy (IO).”
This episode explores multimodal approaches that combine IO and IO-based therapies with locoregional treatments and highlights the essential role of a multidisciplinary care team.”
